OR WAIT null SECS
October 11, 2018
The new facility will include comprehensive mammalian process development and manufacturing capabilities.
October 05, 2018
Luxembourg-based pharmaceutical group, C2 Pharma (formerly known as Centroflora CMS) successfully validated the manufacturing process for two APIs-digoxin and digoxin micron.
October 02, 2018
Industry experts discuss the formulation and development issues that should be considered when addressing scale up from small-scale batches to commercial production.
September 28, 2018
While food, shelter, and clothing are the primal essentials for life, hope-as embodied by modern medicine-has now become part of that human expectation.
September 27, 2018
The sterile-manufacturing contract development manufacturing organization is approved by FDA for viral vector manufacturing fill/finish processing at its biologics facility in Scotland, UK.
September 20, 2018
The contract development and manufacturing organization expanded its analytical chemistry suite and added a new office in Boston, MA.
September 18, 2018
The $425-million acquisition adds formulation development and finished dosage manufacturing capabilities to Cambrex’s existing global API manufacturing network.
September 14, 2018
Avara Pharmaceutical Services acquired Sandoz’s sterile manufacturing facility for injectable medicines in Boucherville, Quebec, Canada.
September 07, 2018
More than 120 healthcare organizations plan to bring competition to generic drug market.
August 17, 2018
The acquisition is expected to support Emergent BioSolutions’ focus on public health threats and emerging infectious disease.